Chattem Gold Bond, pHisoderm Extensions To Launch In Coming Months
This article was originally published in The Rose Sheet
Executive Summary
Chattem is gearing up to launch a slew of new product line extensions within the next few months as its decision to increase its investment in R&D over the past two years begins to pay dividends
You may also be interested in...
Sales & Earnings In Brief
J&J results: Skin care is Johnson & Johnson's fastest growing consumer business and second largest consumer segment, Chairman and CEO William Weldon reports during Jan. 21 sales and earnings call with analysts. Worldwide skin care sales jumped 18.2% in the fourth quarter to $383 mil. compared to the year-ago period, while full year sales grew 12.7% to $1.57 bil., J&J says. Neutrogena, Aveeno and Clean & Clear remain drivers of skin care growth, firm notes. U.S. skin care sales rose 16.4% to $170 mil. in Q4, and for the year, domestic sales were up 11.6% to $778 mil., firm states. Worldwide baby and kids care sales grew 4% to $285 mil. in the fourth quarter and were up 2.6% to $1.16 bil. for the year. Consolidated sales advanced 14.3% to $9.4 bil. in Q4 and net earnings reached $1.44 bil., according to J&J's 1sales and earnings release...
Chattem R&D
Health and beauty aids manufacturer will break ground for $2 mil., 10,000 sq.-ft. research and development facility in Chattanooga, Tenn. in February, company announces. Research facility, which is slated for completion by end of calendar year, will be dedicated to creating line extensions for existing products, according to President, Chief Operating Officer Alec Taylor. Gold Bond sales are expected to be $40 mil.- $42 mil. in 2002, and pHisoderm annual sales are expected to be in $15 mil.-$17 mil. range, Taylor reports during 1presentation at Banc of America Securities Equity and High Yield Research Household Products Conference Jan. 10...
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program